{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:43:39Z","timestamp":1793227419917,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02121-5","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:59:23Z","timestamp":1774263563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prostate-specific antigen clearance after surgery for benign prostate enlargement in a cohort with median prostate-specific antigen greater than 4ng\/ml"],"prefix":"10.1186","volume":"26","author":[{"given":"Ekeoma O","family":"Nwosu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okezie M","family":"Mbadiwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Njideka I","family":"Nwosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinwe A","family":"Nnabugwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikenna N","family":"Anakebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel S","family":"Osaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikenna I","family":"Nnabugwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"2121_CR1","doi-asserted-by":"publisher","first-page":"248","DOI":"10.5213\/inj.2244176.088","volume":"26","author":"HE Lee","year":"2022","unstructured":"Lee HE, Kim B, Yoon HS, Suh J, Oh SJ. Outcome of patients with elevated prostate-specific antigen and lower urinary tract symptoms receiving holmium laser enucleation of the prostate. Int Neurourol J. 2022;26:248\u201357. https:\/\/doi.org\/10.5213\/inj.2244176.088.","journal-title":"Int Neurourol J"},{"key":"2121_CR2","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1002\/cncr.34407","volume":"128","author":"M Hilscher","year":"2022","unstructured":"Hilscher M, R\u00f8der A, Helgstrand JT, Klemann N, Brasso K, Vickers AJ, Stroomberg HV. Risk of prostate cancer and death after benign transurethral resection of the prostate-A 20-year population-based analysis. Cancer. 2022;128:3674\u201380. https:\/\/doi.org\/10.1002\/cncr.34407.","journal-title":"Cancer"},{"key":"2121_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00345-024-05171-2","volume":"42","author":"F Esperto","year":"2024","unstructured":"Esperto F, Cacciatore L, Tedesco F, Raso G, Minore A, Testa A, Ragusa A, Prata F, Alcini A, Salerno A, Flammia GP, Papalia R, Scarpa RM. Prevalence and potential predictors of incidental prostate cancer in patients undergoing surgery for Benign Prostatic obstruction: a retrospective study in the MRI era. World J Urol. 2024;42:485. https:\/\/doi.org\/10.1007\/s00345-024-05171-2.","journal-title":"World J Urol"},{"key":"2121_CR4","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.2147\/IJGM.S357368","volume":"15","author":"CH Yang","year":"2022","unstructured":"Yang CH, Lin YS, Weng WC, Hsu CY, Tung MC, Ou YC. Incidental prostate cancer from prostate with benign biopsies: a predictive and survival analysis from cohort study. Int J Gen Med. 2022;15:2807\u201316. https:\/\/doi.org\/10.2147\/IJGM.S357368.","journal-title":"Int J Gen Med"},{"key":"2121_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00345-021-03771-w","volume":"40","author":"A Bhat","year":"2022","unstructured":"Bhat A, Blachman-Braun R, Herrmann TRW, Shah HN. Are all procedures for benign prostatic hyperplasia created equal? A systematic review on post-procedural PSA dynamics and its correlation with relief of bladder outlet obstruction. World J Urol. 2022;40:889\u2013905. https:\/\/doi.org\/10.1007\/s00345-021-03771-w.","journal-title":"World J Urol"},{"key":"2121_CR6","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s00345-023-04462-4","volume":"41","author":"CV Suartz","year":"2023","unstructured":"Suartz CV, Braz NDSF, Dos Anjos GC, Dos Reis ST, Nahas WC, Antunes AA. The use of statins is related to a lower PSA level after endoscopic enucleation of the prostate with holmium laser (HoLEP) for the treatment of BPH. World J Urol. 2023;41:2149\u201354. https:\/\/doi.org\/10.1007\/s00345-023-04462-4.","journal-title":"World J Urol"},{"key":"2121_CR7","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s11255-013-0474-3","volume":"45","author":"M Pahwa","year":"2013","unstructured":"Pahwa M, Pahwa M, Pahwa AR, Girotra M, Chawla A, Sharma A. Changes in S-PSA after transurethral resection of prostate and its correlation to postoperative outcome. Int Urol Nephrol. 2013;45:943\u20139. https:\/\/doi.org\/10.1007\/s11255-013-0474-3.","journal-title":"Int Urol Nephrol"},{"key":"2121_CR8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1089\/end.2023.0101","volume":"37","author":"AJ Livingston","year":"2023","unstructured":"Livingston AJ, Dvergsten T, Morgan TN. Initial postoperative prostate specific antigen and PSA velocity are important indicators of underlying malignancy after simple prostatectomy. J Endourol. 2023;37:1057\u201362. https:\/\/doi.org\/10.1089\/end.2023.0101.","journal-title":"J Endourol"},{"key":"2121_CR9","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s00345-020-03444-0","volume":"39","author":"E Lambert","year":"2021","unstructured":"Lambert E, Goossens M, Palagonia E, Vollemaere J, Mazzone E, Dell\u2019Oglio P, Pauwels E, De Groote R, D\u2019Hondt F, Mottrie A, De Naeyer G, Schatteman P. Changes in serum PSA after endoscopic enucleation of the prostate are predictive for the future diagnosis of prostate cancer. World J Urol. 2021;39:2621\u20136. https:\/\/doi.org\/10.1007\/s00345-020-03444-0.","journal-title":"World J Urol"},{"key":"2121_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41391-022-00613-7","volume":"26","author":"M Barlow","year":"2023","unstructured":"Barlow M, Down L, Mounce LTA, Merriel SWD, Watson J, Martins T, Bailey SER. Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review. Prostate Cancer Prostatic Dis. 2023;26:249\u201356. https:\/\/doi.org\/10.1038\/s41391-022-00613-7.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2121_CR11","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.urology.2007.01.102","volume":"69","author":"JC Mavropoulos","year":"2007","unstructured":"Mavropoulos JC, Partin AW, Amling CL, Terris MK, Kane CJ, Aronson WJ, Presti JC Jr, Mangold LA, Freedland SJ. Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men? Urology. 2007;69:1138\u201342. https:\/\/doi.org\/10.1016\/j.urology.2007.01.102.","journal-title":"Urology"},{"key":"2121_CR12","doi-asserted-by":"publisher","first-page":"pkaf103","DOI":"10.1093\/jncics\/pkaf103","volume":"9","author":"M Albirair","year":"2025","unstructured":"Albirair M, Nyame Y, Gulati R, Etzioni R. Age-specific racial disparities in the incidence of fatal prostate cancer: an analytic deconstruction. JNCI Cancer Spectr. 2025;9:pkaf103. https:\/\/doi.org\/10.1093\/jncics\/pkaf103.","journal-title":"JNCI Cancer Spectr"},{"key":"2121_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/ilar.43.4.207","volume":"43","author":"RB Dell","year":"2002","unstructured":"Dell RB, Holleran S, Ramakrishnan R. Sample size determination. ILAR J. 2002;43:207\u201313. https:\/\/doi.org\/10.1093\/ilar.43.4.207.","journal-title":"ILAR J"},{"key":"2121_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003698","volume":"211","author":"JS Sandhu","year":"2024","unstructured":"Sandhu JS, Bixler BR, Dahm P, Goueli R, Kirkby E, Stoffel JT, Wilt TJ. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. J Urol. 2024;211:11\u20139. https:\/\/doi.org\/10.1097\/JU.0000000000003698.","journal-title":"J Urol"},{"key":"2121_CR15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1089\/end.2020.0037","volume":"34","author":"MH Khorrami","year":"2020","unstructured":"Khorrami MH, Gholipour F, Zargham M, Mohammadi Sichani M, Izadpanahi MH, Alizadeh F, Khorrami F. Electrocoagulation accounts for a significant portion of discrepancy between preoperative ultrasonography prostate size estimation and resected tissue weight. J Endourol. 2020;34:671\u20135. https:\/\/doi.org\/10.1089\/end.2020.0037.","journal-title":"J Endourol"},{"key":"2121_CR16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/pros.20733","volume":"68","author":"AK Gregorakis","year":"2008","unstructured":"Gregorakis AK, Stefanakis S, Malovrouvas D, Petraki K, Gourgiotis D, Scorilas A. Total and free PSA kinetics in patients without prostate cancer undergoing radical cystoprostatectomy. Prostate. 2008;68:759\u201365. https:\/\/doi.org\/10.1002\/pros.20733.","journal-title":"Prostate"},{"key":"2121_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.4102\/phcfm.v14i1.3736","volume":"14","author":"E Abotsi","year":"2022","unstructured":"Abotsi E, Adanu KK, Bansah EC. Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia. Afr J Prim Health Care Fam Med. 2022;14:e1\u20136. https:\/\/doi.org\/10.4102\/phcfm.v14i1.3736.","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"2121_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.urology.2006.02.026","volume":"68","author":"PF Pinsky","year":"2006","unstructured":"Pinsky PF, Kramer BS, Crawford ED, Grubb RL, Urban DA, Andriole GL, Chia D, Levin DL, Gohagan JK. Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trial. Urology. 2006;68:352\u20136. https:\/\/doi.org\/10.1016\/j.urology.2006.02.026.","journal-title":"Urology"},{"key":"2121_CR19","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00345-020-03321-w","volume":"39","author":"G Magistro","year":"2021","unstructured":"Magistro G, Keller P, Westhofen T, Schott M, Tamalunas A, Weinhold P, Stief CG. The significance of a high preoperative PSA level for the detection of incidental prostate cancer in LUTS patients with large prostates. World J Urol. 2021;39:1481\u20137. https:\/\/doi.org\/10.1007\/s00345-020-03321-w.","journal-title":"World J Urol"},{"key":"2121_CR20","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.urology.2009.06.039","volume":"74","author":"HM Elmansy","year":"2009","unstructured":"Elmansy HM, Elzayat EA, Sampalis JS, Elhilali MM. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy. Urology. 2009;74:1105\u201310. https:\/\/doi.org\/10.1016\/j.urology.2009.06.039.","journal-title":"Urology"},{"key":"2121_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/bju.16795","volume":"136","author":"A Viitala","year":"2025","unstructured":"Viitala A, Anttinen M, M\u00e4kel\u00e4 P, P\u00e4rssinen H, Nurminen P, Sainio T, Saunavaara J, Taimen P, Sequeiros RB, Bostr\u00f6m PJ. Magnetic resonance imaging-guided transurethral ultrasound ablation for benign prostatic obstruction: 1-year clinical outcomes of a phase II study. BJU Int. 2025;136:473\u201383. https:\/\/doi.org\/10.1111\/bju.16795.","journal-title":"BJU Int"},{"key":"2121_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1046\/j.1442-2042.2000.00228.x","volume":"7","author":"Y Furuya","year":"2000","unstructured":"Furuya Y, Akakura K, Tobe T, Ichikawa T, Igarashi T, Ito H. Changes in serum prostate-specific antigen following prostatectomy in patients with benign prostate hyperplasia. Int J Urol. 2000;7:447\u201351. https:\/\/doi.org\/10.1046\/j.1442-2042.2000.00228.x.","journal-title":"Int J Urol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02121-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02121-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02121-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:54:19Z","timestamp":1777517659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02121-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2121"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02121-5","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the bioethics committee of the University of Nigeria Teaching Hospital Ituku-Ozalla, Enugu. Informed consent to participate was obtained from all participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}